Login
Home / SLGL : NASDAQ
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Sol-Gel Technologies Ltd.

$65.94 +$23.79 (+56.44%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$66.79
Day Range
$65.61$67.62
Year Range
$23.15$97.97
Market Cap
215.56M
AVG Volume
45.92K
Trailing/Forward PE
-11.69/-
PEG ratio
-3.13
Dividend Yield
-
Next Earnings Date
2026-11-19
Primary Exchange
NASDAQUS
Revenue (USD)
010M20M30M40M2016201720182019202020212022202320242025
Net Income (USD)
-60M-40M-20M020M2016201720182019202020212022202320242025
Operating Income (USD)
-40M-20M020M40M2016201720182019202020212022202320242025
EBITDA (USD)
-40M-30M-20M-10M010M2016201720182019202020212022202320242025
Cash Flows (USD)
-30M-20M-10M0201620172018201920202021202220232024
EPS (USD)
-3-2-1012016201720182019202020212022202320242025
Expenses (USD)
020M40M60MR&DSG&ACapex2016201720182019202020212022202320242025
Cash & Debt (USD)
020M40M60M80MCashShort Term Debt2016201720182019202020212022202320242025
Debt ratios
00.20.40.62019202020212022202320242025
Margins
-30000%-20000%-10000%0%10000%201720182019202020212022202320242025
Return on Capital
-150%-100%-50%0%50%100%2016201720182019202020212022202320242025
Shares Outstanding
010M20M30M2016201720182019202020212022202320242025
Book Value Per Share (USD)
-505102016201720182019202020212022202320242025
Total Assets (USD)
020M40M60M80M2016201720182019202020212022202320242025
Employee Count
020406080201720182019202020212022202320242025
PE Ratio
0200400600800med 174.11May 22Jul 22Aug 22Oct 22Nov 22Jan 23Mar 23
Free Cash Flow Yield
-2%-1.5%-1%-0.5%0%med 0%Mar 23Jun 23Sep 23Jan 24Apr 24Aug 24Nov 24
Price to Sales
050100150med 12.33Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
0200400600800med 225.46May 22Jul 22Aug 22Oct 22Nov 22Jan 23Mar 23
Price to Book
0102030med 4.7Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Sol-Gel Technologies Ltd.
SLGL
Stockpicker

Video analysis: SLGL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SLGL

Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

globenewswire.com · 20 Aug 2026

Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

NESS ZIONA, Israel, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today announced financial results for the second quarter ended June 30, 2026, and provided a corporate update.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.